CardioExchange Archive

March 10th, 2014

Selections from Richard Lehman’s Literature Review: March 10th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include cognitive function and brain structure in type 2 diabetics after intensive lowering of BP and lipid levels, the association of β-blocker therapy with risks of adverse CV events and deaths in those with ischemic heart disease undergoing noncardiac surgery, and more.

---

February 3rd, 2014

Intensive BP, Lipid Lowering Does Not Protect Against Cognitive Decline in Diabetics

Nicholas Downing, MD

Intensive treatment of blood pressure or cholesterol does not slow the rate of cognitive decline in adults with type 2 diabetes, according to a substudy of the ACCORD trial published in JAMA Internal Medicine. Some 3000 older adults with poorly controlled diabetes, high cardiovascular risk, and no evidence of cognitive impairment were assigned to one of […]

---

November 25th, 2013

Selections from Richard Lehman’s Literature Review: November 25th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include DAPT cessation and coronary events after PCI, statins and cognitive function, and more.

---

November 18th, 2013

No Evidence That Statins Impact Cognitive Function

Larry Husten, PHD

In 2012 the FDA revised the label of statins to include a warning about reports that the drugs had been linked to memory loss or confusion. The FDA action appeared to be based largely on case reports. Despite concerns about this topic that have appeared sporadically in recent years, no high-quality review of the topic has appeared until now. […]

---

October 10th, 2012

Chocolate and Nobel Prizes Linked

Larry Husten, PHD

You don’t have to be a genius to like chocolate, but geniuses are more likely to eat lots of chocolate, at least according to a new paper published in the august New England Journal of Medicine. Franz Messerli reports a highly significant correlation between a nation’s per capita chocolate consumption and the rate at which its […]

---